VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
ATECAlphatec Holdings, Inc.
$8.81$1.3B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

ATEC logoAlphatec Holdings, Inc.(ATEC)Earnings, Financials & Key Ratios

ATEC•NASDAQ
Price updated Jun 19, 2026
SectorHealthcareIndustryMedical DevicesSub-IndustryOrthopedics, spine, and sports medicine
AboutAlphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; squadron lateral retractor designed to maximize patient outcomes; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System that provides minimally invasive pedicle screw placement. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier, as well as EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is headquartered in Carlsbad, California.Show more
  • Revenue$764M+25.0%
  • EBITDA$435K+100.8%
  • Net Income-$143M+11.6%
  • EPS (Diluted)-0.96+15.0%
  • Gross Margin69.6%+0.3%
  • EBITDA Margin0.06%+100.7%
  • Operating Margin-10.75%+51.7%
  • Net Margin-18.76%+29.2%
  • ROE-630.66%-116.2%

ATEC Key Insights

Alphatec Holdings, Inc. (ATEC) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Strong 5Y sales CAGR of 39.5%

✗Weaknesses

  • ✗High debt to equity ratio of 17.2x
  • ✗Profits declining 12.7% over 5 years
  • ✗Weak momentum: RS Rating 13 (bottom 13%)
  • ✗Trading more than 30% below 52-week high
  • ✗Expensive at 36.7x book value

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when ATEC posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

ATEC Price & Volume

Alphatec Holdings, Inc. (ATEC) stock price & volume — 10-year historical chart

Loading chart...

ATEC Growth Metrics

Alphatec Holdings, Inc. (ATEC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years15.22%
5 Years39.46%
3 Years29.62%
TTM-7.36%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM24.27%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM27.83%

Return on Capital

10 Years-30.18%
5 Years-28.22%
3 Years-22.95%
Last Year-13.75%

ATEC Recent Earnings

Alphatec Holdings, Inc. (ATEC) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 3/12 qtrs (25%)●Beat Revenue 6/12 qtrs (50%)
Q2 2026Latest
May 5, 2026
Metric
Actual
Est
EPS
$0.22-2100.0%
$0.01
Rev
$192M-2.7%
$198M
Q1 2026
Feb 24, 2026
Metric
Actual
Est
EPS
$0.06+50.0%
$0.04
Rev
$213M+0.7%
$212M
Q4 2025
Oct 30, 2025
Metric
Actual
Est
EPS
$0.03+200.0%
$0.03
Rev
$197M-6.1%
$209M
Q3 2025
Jul 31, 2025
Metric
Actual
Est
EPS
$0.02+133.3%
$0.06
Rev
$186M+1.6%
$183M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 5, 2026
$0.22vs $0.01-2100.0%
$192Mvs $198M-2.7%
Q1 2026Feb 24, 2026
$0.06vs $0.04+50.0%
$213Mvs $212M+0.7%
Q4 2025Oct 30, 2025
$0.03vs $0.03+200.0%
$197Mvs $209M-6.1%
Q3 2025Jul 31, 2025
$0.02vs $0.06+133.3%
$186Mvs $183M+1.6%
Based on last 12 quarters of dataView full earnings history →

ATEC Peer Comparison

Alphatec Holdings, Inc. (ATEC) competitors in Orthopedics, spine, and sports medicine — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
NUVL logoNUVLNuvalent, Inc.Direct Competitor9.08B123.43-21.10-42.78%
XTNT logoXTNTXtant Medical Holdings, Inc.Direct Competitor61.8M0.4414.6914.21%1.5%3.68%0.56
GMED logoGMEDGlobus Medical, Inc.Direct Competitor10.69B79.2320.2116.65%18.92%13.04%0.03
SYK logoSYKStryker CorporationProduct Competitor117.88B307.8036.6411.16%12.92%15.04%0.66
ZBH logoZBHZimmer Biomet Holdings, Inc.Product Competitor17.22B87.9724.787.2%9.05%5.77%0.59
MDT logoMDTMedtronic plcProduct Competitor101.86B79.3421.983.62%13%9.49%0.59
NUS logoNUSNu Skin Enterprises, Inc.Product Competitor243.72M5.021.58-14.26%3.78%6.84%0.45
NVCR logoNVCRNovoCure LimitedProduct Competitor1.62B14.28-11.708.28%-25.66%-50.82%0.85

Compare ATEC vs Peers

Alphatec Holdings, Inc. (ATEC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs NUVL

Most directly comparable listed peer for ATEC.

Scale Benchmark

vs ISRG

Larger-name benchmark to compare ATEC against a more recognizable public peer.

Peer Set

Compare Top 5

vs NUVL, XTNT, GMED, SYK

ATEC Income Statement

Alphatec Holdings, Inc. (ATEC) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
101.74M91.69M113.43M144.86M243.21M350.87M482.26M611.56M764.15M594.98M
Revenue Growth %
-15.39%-9.87%23.7%27.71%67.89%44.26%37.45%26.81%24.95%-7.36%
Cost of Goods Sold
39.41M28.46M35.83M42.36M85.45M117.81M172.06M187.3M232.27M198.18M
COGS % of Revenue
38.73%31.03%31.59%29.24%35.13%33.58%35.68%30.63%30.4%-
Gross Profit
62.33M▲ 0%
63.24M▲ 1.5%
77.59M▲ 22.7%
102.5M▲ 32.1%
157.76M▲ 53.9%
233.06M▲ 47.7%
310.2M▲ 33.1%
424.26M▲ 36.8%
531.89M▲ 25.4%
533.27M▲ 0%
Gross Margin %
61.27%68.97%68.41%70.76%64.87%66.42%64.32%69.37%69.6%89.63%
Gross Profit Growth %
-18.13%1.45%22.7%32.1%53.91%47.73%33.1%36.77%25.37%-
Operating Expenses
69.99M83.23M124.87M161.36M285.82M380.03M483.6M560.43M614.02M590.23M
OpEx % of Revenue
68.79%90.77%110.09%111.39%117.52%108.31%100.28%91.64%80.35%-
Selling, General & Admin
64.38M72.51M101.71M129.16M229.27M300.01M374.08M450.2M498.53M493.34M
SG&A % of Revenue
63.28%79.08%89.67%89.16%94.27%85.51%77.57%73.61%65.24%-
Research & Development
4.92M9.98M13.85M18.75M32.02M44.03M70.11M80.72M76.27M77.25M
R&D % of Revenue
4.84%10.89%12.21%12.94%13.16%12.55%14.54%13.2%9.98%-
Other Operating Expenses
0738K9.31M13.46M24.53M35.99M39.4M29.51M39.22M3M
Operating Income
-9M▲ 0%
-22.44M▼ 149.3%
-47.28M▼ 110.7%
-58.86M▼ 24.5%
-128.06M▼ 117.6%
-146.97M▼ 14.8%
-173.4M▼ 18.0%
-136.17M▲ 21.5%
-82.13M▲ 39.7%
-56.96M▲ 0%
Operating Margin %
-8.85%-24.47%-41.68%-40.63%-52.65%-41.89%-35.95%-22.27%-10.75%-9.57%
Operating Income Growth %
41.45%-149.25%-110.68%-24.51%-117.55%-14.77%-17.98%21.47%39.69%-
EBITDA
-1.52M-15.65M-38.77M-47.23M-97.88M-103.05M-113.71M-52.85M435K4.42M
EBITDA Margin %
-1.5%-17.07%-34.18%-32.6%-40.25%-29.37%-23.58%-8.64%0.06%0.74%
EBITDA Growth %
49.49%-928.32%-147.7%-21.83%-107.24%-5.28%-10.35%53.52%100.82%106.07%
D&A (Non-Cash Add-back)
7.48M6.79M8.51M11.63M30.17M43.93M59.68M83.32M82.56M61.38M
EBIT
3.04M-23.03M-47.28M-66.47M-137.05M-146.5M-170.27M-137.19M-122.26M-83.64M
Net Interest Income
-7.62M-7.14M-9.87M-12.37M-7.11M-5.5M-16.64M-24.88M-21.14M-30.37M
Interest Income
009.87M0000000
Interest Expense
7.62M7.14M012.37M7.11M5.5M16.64M24.88M21.14M25.42M
Other Income/Expense
4.43M-7.73M-9.87M-19.99M-16.11M-5.03M-13.52M-25.9M-61.27M-68.33M
Pretax Income
-4.57M▲ 0%
-30.17M▼ 559.6%
-57.14M▼ 89.4%
-78.85M▼ 38.0%
-144.16M▼ 82.8%
-152.01M▼ 5.4%
-186.91M▼ 23.0%
-162.07M▲ 13.3%
-143.4M▲ 11.5%
-125.29M▲ 0%
Pretax Margin %
-4.5%-32.9%-50.38%-54.43%-59.27%-43.32%-38.76%-26.5%-18.77%-21.06%
Income Tax
-34K-1.36M-239K145K-1.13M-716K-277K50K-45K69K
Effective Tax Rate %
0.74%4.51%0.42%-0.18%0.78%0.47%0.15%-0.03%0.03%-0.06%
Net Income
-2.29M▲ 0%
-28.98M▼ 1163.1%
-57M▼ 96.7%
-78.99M▼ 38.6%
-143.03M▼ 81.1%
-151.29M▼ 5.8%
-186.64M▼ 23.4%
-162.12M▲ 13.1%
-143.36M▲ 11.6%
-125.36M▲ 0%
Net Margin %
-2.25%-31.6%-50.25%-54.53%-58.81%-43.12%-38.7%-26.51%-18.76%-21.07%
Net Income Growth %
92.43%-1163.08%-96.73%-38.58%-81.07%-5.78%-23.36%13.14%11.57%24.27%
Net Income (Continuing)
-4.54M-28.81M-56.9M-78.99M-143.03M-151.29M-186.64M-162.12M-143.36M-125.36M
Discontinued Operations
2.25M0-100K0000000
Minority Interest
0000000000
EPS (Diluted)
-0.17▲ 0%
-0.82▼ 382.4%
-1.09▼ 32.9%
-1.18▼ 8.3%
-1.50▼ 27.1%
-1.47▲ 2.0%
-1.54▼ 4.8%
-1.13▲ 26.6%
-0.96▲ 15.0%
-0.81▲ 0%
EPS Growth %
95.18%-382.35%-32.93%-8.26%-27.12%2%-4.76%26.62%15.04%27.83%
EPS (Basic)
-0.18-0.82-1.09-1.18-1.50-1.47-1.54-1.13-0.96-
Diluted Shares Outstanding
13.28M35.31M52.23M67.02M96.2M103.37M121.24M142.95M150.06M154.05M
Basic Shares Outstanding
12.79M35.31M52.23M67.02M96.2M103.37M121.24M142.95M150.06M154.05M
Dividend Payout Ratio
----------

ATEC Balance Sheet

Alphatec Holdings, Inc. (ATEC) balance sheet — assets, liabilities & shareholders' equity

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
66.48M75.54M108.32M184.16M331.16M255.63M451.09M417.4M450.88M456.17M
Cash & Short-Term Investments
22.47M29.05M47.11M107.77M187.25M84.7M220.97M138.84M160.81M139.91M
Cash Only
22.47M29.05M47.11M107.77M187.25M84.7M220.97M138.84M160.81M139.91M
Short-Term Investments
0000000000
Accounts Receivable
14.82M15.45M16.15M24.6M41.89M60.06M72.61M82.99M97.3M112.79M
Days Sales Outstanding
53.1861.4851.9761.9962.8762.4854.9649.5346.4862.39
Inventory
27.29M28.77M34.85M46M91.7M101.52M136.84M175.26M169.44M186.03M
Days Inventory Outstanding
252.79368.95355.03396.37391.71314.54290.29341.54266.28318.67
Other Current Assets
131K242K10.2M5.79M09.36M20.67M20.31M23.32M17.44M
Total Non-Current Assets
18.18M53.94M66.63M81.06M240.9M265.33M354.12M358.31M340.33M343.31M
Property, Plant & Equipment
12.67M13.23M21.58M37.85M112.68M130.31M176.25M191.09M166.55M168.65M
Fixed Asset Turnover
8.03x6.93x5.26x3.83x2.16x2.69x2.74x3.20x4.59x3.50x
Goodwill
013.9M13.9M13.9M39.69M47.37M73M70.98M75.21M74.47M
Intangible Assets
5.25M26.41M25.61M24.72M85.27M82.78M102.45M93.52M93.45M90.02M
Long-Term Investments
5M5M5M4M000000
Other Non-Current Assets
264K401K546K599K3.25M4.87M2.42M2.72M5.12M10.17M
Total Assets
84.66M▲ 0%
129.48M▲ 52.9%
174.95M▲ 35.1%
265.22M▲ 51.6%
572.05M▲ 115.7%
520.97M▼ 8.9%
805.21M▲ 54.6%
775.71M▼ 3.7%
791.21M▲ 2.0%
799.48M▲ 0%
Asset Turnover
1.20x0.71x0.65x0.55x0.43x0.67x0.60x0.79x0.97x0.75x
Asset Growth %
-10.12%52.94%35.12%51.6%115.69%-8.93%54.56%-3.66%2%12.15%
Total Current Liabilities
29.74M30.61M36.39M58.31M101.09M138.87M157.57M153.03M219.18M240.24M
Accounts Payable
3.88M4.4M7.77M17.6M25.74M34.74M48.98M52.98M40.89M46.04M
Days Payables Outstanding
35.9256.4279.17151.64109.94107.64103.92103.2564.2678.76
Short-Term Debt
3.31M3.28M1.8M5.08M342K14.95M1.81M1.66M70.82M72.17M
Deferred Revenue (Current)
19.11M-3K0015.26M11.96M13.91M10.47M10.44M42.47M
Other Current Liabilities
15.11M19.71M18.78M23.38M4.29M5.64M56.52M6.82M63.67M111.57M
Current Ratio
2.24x2.47x2.98x3.16x3.28x1.84x2.86x2.73x2.06x1.90x
Quick Ratio
1.32x1.53x2.02x2.37x2.37x1.11x1.99x1.58x1.28x1.12x
Cash Conversion Cycle
270.05374.01327.83306.72344.64269.38241.33287.82248.49302.31
Total Non-Current Liabilities
81.58M81.29M66.32M49.43M391.54M416.76M545.91M613.25M536M540.98M
Long-Term Debt
37.77M42.3M53.38M38M326.49M349.51M511.04M574.52M525.27M507.89M
Capital Lease Obligations
092K989K78K24.38M26.56M23.68M27.3M23.86M98.1M
Deferred Tax Liabilities
0000000000
Other Non-Current Liabilities
43.81M38.9M11.95M11.35M37.77M37.65M8.64M8.29M-15.3M8.27M
Total Liabilities
111.32M111.9M102.71M107.74M492.63M555.63M703.49M766.28M755.18M781.22M
Total Debt
41.07M3.28M56.18M43.16M355.43M395.86M541.68M609.94M619.95M603.06M
Net Debt
18.61M-25.78M9.06M-64.61M168.18M311.17M320.71M471.1M459.14M463.15M
Debt / Equity
-0.19x0.78x0.27x4.48x-5.33x64.65x17.21x33.03x
Debt / EBITDA
--------1425.17x136.32x
Net Debt / EBITDA
--------1055.50x104.69x
Interest Coverage
0.40x-3.23x--5.37x-19.28x-26.61x-10.23x-5.51x-5.78x-3.29x
Total Equity
-26.66M▲ 0%
17.57M▲ 165.9%
72.23M▲ 311.0%
157.48M▲ 118.0%
79.42M▼ 49.6%
-34.67M▼ 143.6%
101.72M▲ 393.4%
9.43M▼ 90.7%
36.03M▲ 281.9%
18.26M▲ 0%
Equity Growth %
36.37%165.92%311.03%118.02%-49.57%-143.65%393.42%-90.73%281.91%379.28%
Book Value per Share
-2.010.501.382.350.83-0.340.840.070.240.12
Total Shareholders' Equity
-26.66M17.57M72.23M157.48M79.42M-34.67M101.72M9.43M36.03M18.26M
Common Stock
2K4K6K8K10K11K14K14K15K16K
Retained Earnings
-459.46M-501.92M-558.92M-638M-782.33M-932.32M-1.12B-1.28B-1.42B-1.46B
Treasury Stock
-97K-97K-97K-97K-25.1M-25.1M-25.1M-25.1M-25.1M-25.1M
Accumulated OCI
1.09M1.06M1.09M1.2M-5.99M-10.79M-8.32M-13.68M-4.43M-6.45M
Minority Interest
0000000000

ATEC Cash Flow Statement

Alphatec Holdings, Inc. (ATEC) cash flow — operating, investing & free cash flow history

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
-8.73M-25.61M-33.12M-46.41M-73.32M-75.13M-78.48M-44.65M45.23M51.56M
Operating CF Margin %
-8.58%-27.93%-29.2%-32.04%-30.15%-21.41%-16.27%-7.3%5.92%-
Operating CF Growth %
12.35%-193.37%-29.34%-40.13%-57.97%-2.48%-4.46%43.11%201.3%821.44%
Net Income
-2.29M-28.98M-57M-78.99M-143.03M-151.29M-186.64M-162.12M-143.36M-125.36M
Depreciation & Amortization
7.48M6.79M8.51M11.63M30.17M43.93M59.68M83.32M105.08M88.73M
Stock-Based Compensation
3.9M5.3M10.96M17.66M36.45M40.56M81.24M73.28M73.72M75.06M
Deferred Taxes
-36K-1.41M-438K9K000000
Other Non-Cash Items
-7.48M2.39M13.23M19.23M28.15M15.61M21.41M28.15M29.92M41.61M
Working Capital Changes
-10.3M-9.71M-8.38M-15.95M-25.05M-23.94M-54.18M-67.27M-20.13M-28.48M
Change in Receivables
4.15M-396K-1.3M-7.48M-10.14M-18.83M-12.79M-14.59M-21.88M-21.84M
Change in Inventory
258K-6.02M-14.71M-18.19M-27.75M-20.7M-45.56M-54.66M13.54M15.91M
Change in Payables
-2.59M16K6M7.13M757K9.8M6.99M9.67M-11.16M963K
Cash from Investing
-6.5M-21.67M-13.03M-23.86M-157.76M-58.28M-141.97M-93.14M-53.41M-61.69M
Capital Expenditures
-7.6M-6.91M-13.03M-23.13M-68.54M-49.45M-80.51M-93.14M-42.45M-44.61M
CapEx % of Revenue
7.47%7.54%11.49%15.97%28.18%14.09%16.69%15.23%5.56%7.5%
Acquisitions
1.1M-15.1M00-83.23M0-55M000
Investments
----------
Other Investing
1.1M348K0-728K0-8.83M-6.47M0-10.96M-17.08M
Cash from Financing
17.82M53.88M64.18M130.83M311.97M31.23M356.92M56.21M30.02M-2.52M
Debt Issued (Net)
-6.57M1.98M8.36M19.85M271.25M35M149.66M58.8M74.81M-1.1M
Equity Issued (Net)
24.39M51.9M55.83M111.04M100.86M0212.12M-560K0-54K
Dividends Paid
0000000000
Share Repurchases
0000-30.96M00000
Other Financing
24.39M00-58K-60.15M-3.77M-4.86M-2.03M-44.8M-1.36M
Net Change in Cash
2.84M▲ 0%
6.59M▲ 131.9%
18.06M▲ 174.1%
60.65M▲ 235.9%
79.48M▲ 31.0%
-102.55M▼ 229.0%
136.27M▲ 232.9%
-82.13M▼ 160.3%
21.97M▲ 126.7%
-13.33M▲ 0%
Free Cash Flow
-16.32M▲ 0%
-32.52M▼ 99.2%
-46.15M▼ 41.9%
-70.3M▼ 52.3%
-141.86M▼ 101.8%
-133.41M▲ 6.0%
-165.46M▼ 24.0%
-137.79M▲ 16.7%
2.78M▲ 102.0%
6.95M▲ 0%
FCF Margin %
-16.05%-35.47%-40.69%-48.53%-58.33%-38.02%-34.31%-22.53%0.36%1.17%
FCF Growth %
14.56%-99.22%-41.91%-52.32%-101.8%5.95%-24.02%16.72%102.01%108.61%
FCF per Share
-1.23-0.92-0.88-1.05-1.47-1.29-1.36-0.960.020.05
FCF Conversion (FCF/Net Income)
3.81x0.88x0.58x0.59x0.51x0.50x0.42x0.28x-0.32x-0.06x
Interest Paid
4.7M5.14M5.97M6.33M5.03M3.86M17.27M20.32M00
Taxes Paid
107K134K161K190K223K272K333K275K00

ATEC Key Ratios

Alphatec Holdings, Inc. (ATEC) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)
--164.87%-126.94%-68.78%-120.75%-676.09%-556.7%-291.71%-630.66%-443.09%
Return on Invested Capital (ROIC)
---97.02%-50.69%-56.42%-42.07%-37.21%-22.62%-12.63%-8.99%
Gross Margin
61.27%68.97%68.41%70.76%64.87%66.42%64.32%69.37%69.6%89.63%
Net Margin
-2.25%-31.6%-50.25%-54.53%-58.81%-43.12%-38.7%-26.51%-18.76%-21.07%
Debt / Equity
-0.19x0.78x0.27x4.48x-5.33x64.65x17.21x33.03x
Interest Coverage
0.40x-3.23x--5.37x-19.28x-26.61x-10.23x-5.51x-5.78x-3.29x
FCF Conversion
3.81x0.88x0.58x0.59x0.51x0.50x0.42x0.28x-0.32x-0.06x
Revenue Growth
-15.39%-9.87%23.7%27.71%67.89%44.26%37.45%26.81%24.95%-7.36%
Related:ATEC Dividend History·ATEC Revenue History·ATEC Price History·ATEC P/E History·ATEC Financial Ratios·ATEC Institutional Holders

ATEC SEC Filings & Documents

Alphatec Holdings, Inc. (ATEC) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 5, 2026·SEC

Material company update

Mar 3, 2026·SEC

Material company update

Feb 24, 2026·SEC

10-K Annual Reports

3
FY 2026

Feb 24, 2026·SEC

FY 2025

Feb 26, 2025·SEC

FY 2024

Feb 27, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 5, 2026·SEC

FY 2025

Oct 30, 2025·SEC

FY 2025

Jul 31, 2025·SEC

ATEC Frequently Asked Questions

Alphatec Holdings, Inc. (ATEC) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Alphatec Holdings, Inc. (ATEC) reported $595.0M in revenue for fiscal year 2025. This represents a 3239% increase from $17.8M in 2004.

Alphatec Holdings, Inc. (ATEC) grew revenue by 25.0% over the past year. This is strong growth.

Alphatec Holdings, Inc. (ATEC) reported a net loss of $125.4M for fiscal year 2025.

Dividend & Returns

Alphatec Holdings, Inc. (ATEC) has a return on equity (ROE) of -630.7%. Negative ROE indicates the company is unprofitable.

Alphatec Holdings, Inc. (ATEC) generated $6.9M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in ATEC back in 2004?

Total return calculator · dividends reinvested · 22+ years of data

See returns →

How much would $100/month in ATEC be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →